Acorda Therapeutics, Inc announced that Ampyra (dalfampridine) Extended Release tablets, 10 mg is now available by prescription in the United States and Puerto Rico. Ampyra was approved on January 22, 2010 by the US Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS).
Read the rest of the article here.
